What is the relative effectiveness and safety of second-generation antidepressants?

MOspace/Manakin Repository

Breadcrumbs Navigation

What is the relative effectiveness and safety of second-generation antidepressants?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/7402

[-] show simple item record

dc.contributor.author Gallimore, Casey en_US
dc.date.accessioned 2010-05-26T20:33:11Z
dc.date.available 2010-05-26T20:33:11Z
dc.date.issued 2008-12
dc.identifier.citation Evidence Based Practice 11(12): 06-07. en_US
dc.identifier.uri http://hdl.handle.net/10355/7402
dc.description.abstract While some small differences have been found between agents, selective serotonin reuptake inhibitors (SSRIs) and non-SSRI second-generation antidepressants generally have similar efficacy and discontinuation rates when used to treat depression. However, side effect profiles differ by agent: more blood pressure elevation with venlafaxine, more weight gain with mirtazapine, and less sexual dysfunction with bupropion. (SOR A, based on systematic reviews and meta-analyses.) en_US
dc.language.iso en_US en_US
dc.publisher Family Physicians Inquiries Network en_US
dc.relation.ispartof Evidence Based Practice 11(12): 06-07. en_US
dc.relation.ispartofseries Help Desk Answers en_US
dc.subject.lcsh Drugs -- Side effects en_US
dc.subject.lcsh Depression, Mental -- Treatment en_US
dc.title What is the relative effectiveness and safety of second-generation antidepressants? en_US
dc.type Article en_US
dc.relation.ispartofcommunity University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network. Evidence Based Practice. en_US
dc.relation.ispartofcollection Evidence Based Practice, 2008 en_US


This item appears in the following Collection(s)

[-] show simple item record